tiprankstipranks
Trending News
More News >
Creades AB Class A (SE:CRED.A)
:CRED.A
Advertisement

Creades AB (CRED.A) AI Stock Analysis

Compare
1 Followers

Top Page

SE:CRED.A

Creades AB

(LSE:CRED.A)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 4o)
Rating:74Outperform
Price Target:
kr90.00
▲(12.99% Upside)
Creades AB's strong valuation and solid financial performance are the primary drivers of its score. The low P/E ratio and healthy dividend yield suggest undervaluation, while profitability metrics are robust despite revenue decline concerns. Technical indicators show mixed momentum, which slightly tempers the overall score.

Creades AB (CRED.A) vs. iShares MSCI Sweden ETF (EWD)

Creades AB Business Overview & Revenue Model

Company DescriptionCreades AB is a private equity and venture capital investment firm specializing in seed/startup, early, mid & late venture, emerging growth, middle market, growth capital and buyout investments. The firm typically invests in small and medium-sized public and private companies. It focuses on Swedish companies. The firm seeks to invest between SEK100 ($15.51 million) and SEK300 million ($46.53 million). The firm prefers to take a majority stake and seat on the board of directors of its portfolio companies. The firm uses personal and balance sheet capital for making investments. Creades AB was founded in 2011 and is based in Stockholm, Sweden.
How the Company Makes MoneyCreades AB generates revenue primarily through its investments in portfolio companies. The company makes money by realizing capital gains from the sale of its investments, which can occur through various exit strategies such as public offerings, mergers, or acquisitions. In addition, Creades can earn management fees and performance-based fees from its investments, depending on the agreements in place with portfolio companies. The company also benefits from dividends or profit-sharing arrangements from its investments, contributing to its overall earnings. Strategic partnerships and collaborations with other investment firms and industry experts enhance its investment capabilities and market insights, thereby potentially increasing its revenue streams.

Creades AB Financial Statement Overview

Summary
Creades AB presents a robust financial standing with strong profitability and minimal leverage. The impressive recovery in revenue and profit margins, alongside a solid balance sheet with high equity ratios, reflect financial health. However, the historical volatility in revenue calls for cautious optimism. The cash flow stability complements the overall positive outlook, though attention to free cash flow trends is advisable.
Income Statement
75
Positive
Creades AB shows a strong recovery in its revenue and profit margins. The TTM revenue grew significantly by 21.08% from the previous year, and the net profit margin is robust at 91.06% for the TTM period. The company has maintained excellent EBIT and EBITDA margins at 90.57% and 60.69%, respectively. However, the negative revenue and profit in 2022 indicate volatility and potential risks.
Balance Sheet
80
Positive
The balance sheet of Creades AB displays financial stability with no debt and a high equity ratio of 99.01% in the TTM period. The return on equity is impressive at 13.72%, indicating effective use of equity to generate profit. The company’s assets are predominantly equity-financed, reflecting a low-risk financial structure.
Cash Flow
70
Positive
The cash flow statement reveals a stable operating cash flow to net income ratio of 0.12 for the TTM period, indicating moderate conversion efficiency. Although free cash flow decreased by 10.53% in the TTM period, the company maintains a healthy cash position with free cash flow to net income ratio of 0.12, suggesting sustainable cash generation.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.32B543.00M538.00M-4.19B4.47B4.01B
Gross Profit1.32B1.26B509.00M-4.19B4.47B4.01B
EBITDA1.24B1.18B524.00M-3.96B4.22B3.66B
Net Income1.25B1.20B558.00M-3.95B4.19B3.65B
Balance Sheet
Total Assets10.95B10.31B9.32B9.05B13.52B8.34B
Cash, Cash Equivalents and Short-Term Investments720.00M717.00M299.00M613.00M467.00M640.00M
Total Debt9.00M10.00M2.00M3.00M6.00M7.00M
Total Liabilities232.00M153.00M147.00M245.00M575.00M389.00M
Stockholders Equity10.72B10.16B9.18B8.81B12.95B7.95B
Cash Flow
Free Cash Flow129.00M190.00M205.00M25.00M89.00M16.00M
Operating Cash Flow129.00M190.00M205.00M25.00M89.00M16.00M
Investing Cash Flow561.00M438.00M-329.00M311.00M-1.07B424.00M
Financing Cash Flow-216.00M-210.00M-190.00M-190.00M805.00M-262.00M

Creades AB Technical Analysis

Technical Analysis Sentiment
Positive
Last Price79.65
Price Trends
50DMA
77.56
Positive
100DMA
77.59
Positive
200DMA
76.43
Positive
Market Momentum
MACD
0.40
Negative
RSI
65.49
Neutral
STOCH
98.03
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:CRED.A, the sentiment is Positive. The current price of 79.65 is above the 20-day moving average (MA) of 76.60, above the 50-day MA of 77.56, and above the 200-day MA of 76.43, indicating a bullish trend. The MACD of 0.40 indicates Negative momentum. The RSI at 65.49 is Neutral, neither overbought nor oversold. The STOCH value of 98.03 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:CRED.A.

Creades AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
kr5.35B7.605.98%-0.22%-58.80%
74
Outperform
kr10.88B8.7112.24%1.97%-6.84%14.17%
69
Neutral
€8.92B43.4815.85%9.32%-7.55%
64
Neutral
€5.75B654.170.16%3.12%-96.46%-99.03%
63
Neutral
€21.09B179.99-13.33%0.97%22.27%-145.59%
62
Neutral
kr12.78B44.482.64%3.41%-13.86%-77.94%
55
Neutral
$13.29B17.4210.03%0.93%7.13%-12.93%
* Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:CRED.A
Creades AB
79.65
4.58
6.10%
SE:RATO.B
Ratos AB
39.56
6.93
21.24%
SE:BURE
Bure Equity AB
282.60
-95.67
-25.29%
SE:SVOL.B
Svolder AB Class B
54.40
-3.58
-6.18%
SE:MCAP
MedCap AB
580.00
99.50
20.71%
SE:ORES
Investment AB Oresund
117.20
4.02
3.55%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 04, 2025